A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome and non-alcoholic-fatty-liver disease (NAFLD). Vitamin D supplementation may exert positive effects on liver biochemistry in patients with NAFLD; however, its effects on PCOS are unknown. This randomized, double-blind, placebo...

Full description

Bibliographic Details
Main Authors: Zeeshan Javed, Maria Papageorgiou, Harshal Deshmukh, Eric S. Kilpatrick, Vincent Mann, Lynsey Corless, George Abouda, Alan S. Rigby, Stephen L. Atkin, Thozhukat Sathyapalan
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Nutrients
Subjects:
polycystic ovary syndrome
vitamin D
liver markers
cardiovascular risk factors
hormones
Online Access:http://www.mdpi.com/2072-6643/11/1/188

Internet

http://www.mdpi.com/2072-6643/11/1/188

Similar Items